Literature DB >> 21458454

Malnutrition impairs interferon signaling through mTOR and FoxO pathways in patients with chronic hepatitis C.

Masao Honda1, Kenji Takehana, Akito Sakai, Yusuke Tagata, Takayoshi Shirasaki, Shinobu Nishitani, Takahiko Muramatsu, Tatsuya Yamashita, Yasunari Nakamoto, Eishiro Mizukoshi, Yoshio Sakai, Taro Yamashita, Mikiko Nakamura, Tetsuro Shimakami, Minkyung Yi, Stanley M Lemon, Tetsuo Suzuki, Takaji Wakita, Shuichi Kaneko.   

Abstract

BACKGROUND & AIMS: Patients with advanced chronic hepatitis C (CH-C) often are malnourished, but the effects of malnutrition on interferon (IFN) signaling and response to treatment have not been determined. We assessed the importance of the nutritional state of the liver on IFN signaling and treatment response.
METHODS: We studied data from 168 patients with CH-C who were treated with the combination of pegylated-IFN and ribavirin. Plasma concentrations of amino acids were measured by mass spectrometry. Liver gene expression profiles were obtained from 91 patients. Huh-7 cells were used to evaluate the IFN signaling pathway, mammalian target of rapamycin complex 1 (mTORC1), and forkhead box O (FoxO). Antiviral signaling induced by branched-chain amino acids (BCAAs) was determined using the in vitro hepatitis C virus replication system.
RESULTS: Multivariate logistic regression analysis showed that Fischer's ratio was associated significantly with nonresponders, independent of interleukin-28B polymorphisms or the histologic stage of the liver. Fischer's ratio was correlated inversely with the expression of BCAA transaminase 1, and was affected by hepatic mTORC1 signaling. IFN stimulation was impaired substantially in Huh-7 cells grown in medium that was low in amino acid concentration, through repressed mTORC1 signaling, and increased Socs3 expression, which was regulated by Foxo3a. BCAA could restore impaired IFN signaling and inhibit hepatitis C virus replication under conditions of malnutrition.
CONCLUSIONS: Malnutrition impaired IFN signaling by inhibiting mTORC1 and activating Socs3 signaling through Foxo3a. Increasing BCAAs to up-regulate IFN signaling might be used as a new therapeutic approach for patients with advanced CH-C.
Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21458454     DOI: 10.1053/j.gastro.2011.03.051

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  22 in total

1.  SOCS3 in retinal neurons and glial cells suppresses VEGF signaling to prevent pathological neovascular growth.

Authors:  Ye Sun; Meihua Ju; Zhiqiang Lin; Thomas W Fredrick; Lucy P Evans; Katherine T Tian; Nicholas J Saba; Peyton C Morss; William T Pu; Jing Chen; Andreas Stahl; Jean-Sébastien Joyal; Lois E H Smith
Journal:  Sci Signal       Date:  2015-09-22       Impact factor: 8.192

2.  Metformin suppresses expression of the selenoprotein P gene via an AMP-activated kinase (AMPK)/FoxO3a pathway in H4IIEC3 hepatocytes.

Authors:  Hiroaki Takayama; Hirofumi Misu; Hisakazu Iwama; Keita Chikamoto; Yoshiro Saito; Koji Murao; Atsushi Teraguchi; Fei Lan; Akihiro Kikuchi; Reina Saito; Natsumi Tajima; Takayoshi Shirasaki; Seiichi Matsugo; Ken-ichi Miyamoto; Shuichi Kaneko; Toshinari Takamura
Journal:  J Biol Chem       Date:  2013-11-20       Impact factor: 5.157

3.  Regulation of FOXO3 by phosphorylation and methylation in hepatitis C virus infection and alcohol exposure.

Authors:  Irina Tikhanovich; Sudhakiranmayi Kuravi; Roosevelt V Campbell; Kusum K Kharbanda; Antonio Artigues; Maria T Villar; Steven A Weinman
Journal:  Hepatology       Date:  2013-11-20       Impact factor: 17.425

Review 4.  Forkhead box class O transcription factors in liver function and disease.

Authors:  Irina Tikhanovich; Josiah Cox; Steven A Weinman
Journal:  J Gastroenterol Hepatol       Date:  2013-08       Impact factor: 4.029

5.  Eicosapentaenoic acid down-regulates expression of the selenoprotein P gene by inhibiting SREBP-1c protein independently of the AMP-activated protein kinase pathway in H4IIEC3 hepatocytes.

Authors:  Natsumi Tajima-Shirasaki; Kiyo-Aki Ishii; Hiroaki Takayama; Takayoshi Shirasaki; Hisakazu Iwama; Keita Chikamoto; Yoshiro Saito; Yasumasa Iwasaki; Atsushi Teraguchi; Fei Lan; Akihiro Kikuchi; Yumie Takeshita; Koji Murao; Seiichi Matsugo; Shuichi Kaneko; Hirofumi Misu; Toshinari Takamura
Journal:  J Biol Chem       Date:  2017-05-02       Impact factor: 5.157

Review 6.  Branched-chain amino acids in liver diseases.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 7.  Branched-chain amino acids in liver diseases.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  Transl Gastroenterol Hepatol       Date:  2018-07-30

8.  MicroRNA-27a regulates lipid metabolism and inhibits hepatitis C virus replication in human hepatoma cells.

Authors:  Takayoshi Shirasaki; Masao Honda; Tetsuro Shimakami; Rika Horii; Taro Yamashita; Yoshio Sakai; Akito Sakai; Hikari Okada; Risa Watanabe; Seishi Murakami; MinKyung Yi; Stanley M Lemon; Shuichi Kaneko
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

Review 9.  Leucine Metabolism in T Cell Activation: mTOR Signaling and Beyond.

Authors:  Elitsa A Ananieva; Jonathan D Powell; Susan M Hutson
Journal:  Adv Nutr       Date:  2016-07-15       Impact factor: 8.701

10.  Hepatitis C and alcohol exacerbate liver injury by suppression of FOXO3.

Authors:  Batbayar Tumurbaatar; Irina Tikhanovich; Zhuan Li; Jinyu Ren; Robert Ralston; Sudhakiranmayi Kuravi; Roosevelt Campbell; Gaurav Chaturvedi; Ting-Ting Huang; Jie Zhao; Junfang Hao; Maura O'Neil; Steven A Weinman
Journal:  Am J Pathol       Date:  2013-11-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.